Validation of the adjusted multi-biomarker disease activity score as a prognostic test for radiographic progression in rheumatoid arthritis: a combined analysis of multiple studies

BACKGROUND: The multi-biomarker disease activity (MBDA) test measures 12 serum protein biomarkers to quantify disease activity in RA patients. A newer version of the MBDA score, adjusted for age, sex, and adiposity, has been validated in two cohorts (OPERA and BRASS) for predicting risk for radiogra...

Descripción completa

Detalles Bibliográficos
Autores principales: Curtis, Jeffrey R., Weinblatt, Michael E., Shadick, Nancy A., Brahe, Cecilie H., Østergaard, Mikkel, Hetland, Merete Lund, Saevarsdottir, Saedis, Horton, Megan, Mabey, Brent, Flake, Darl D., Ben-Shachar, Rotem, Sasso, Eric H., Huizinga, T. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784276/
https://www.ncbi.nlm.nih.gov/pubmed/33397438
http://dx.doi.org/10.1186/s13075-020-02389-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784276/
https://www.ncbi.nlm.nih.gov/pubmed/33397438
http://dx.doi.org/10.1186/s13075-020-02389-4

Ejemplares similares